Our researchers are working to develop new therapies to treat childhood sarcoma and other complex pediatric tumors. Patients have the opportunity to be the first to benefit from these groundbreaking therapies.
Current studies include:
Eribulin Mesylate: This study investigates the safety and effects of eribulin mesylate, a medication used to treat many types of cancer, in patients with various types of childhood sarcoma.
Pediatric Solid Tumor: This study seeks to determine the maximum safe dose of the drug MM-298 in combination with the chemotherapy drug Cyclophosphamide in treating solid tumors in children.
